S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
SI · Shoulder Innovations, Inc.
NEW YORK STOCK EXCHANGE, INC. - BOATS Real Time Price • USD
Shoulder Innovations Inc (SI)
NEW YORK STOCK EXCHANGE, INC.
Health Care
$19.35
+0.67
(+3.56%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$19.35
$18.65
$19.88
52-WEEK RANGE
$19.35
$10.92
$24.59
What's happening
- SI is up 3.56% today, trading at $19.35. — Live quote
- Volume today (7,612) is well below its 3-month average of 123,250. (Finnhub fundamentals)
- Reports earnings on 2026-11-05, 14 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.46 actual vs. $-0.47 estimated (+2.9%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 5
Buy 6
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (12 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
SI
+30.91%
vs S&P 500
+18.13%
1-YEAR RETURN
SI
+49.28%
vs S&P 500
+34.72%
6-MONTH RETURN
SI
+32.58%
3-MONTH RETURN
SI
-10.00%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-0.46
Est. $-0.47
BEAT +2.9%
2026-04-26 (Q1 2026)
$-0.41
Est. $-0.42
BEAT +3.1%
2026-01-26 (Q4 2025)
$-0.38
Est. $-0.33
MISS -14.5%
2025-10-26 (Q3 2025)
$-0.64
Est. $-0.32
MISS -101.8%
Valuation Measures & Ratios
Enterprise Value4$380.1M
Forward P/E5—
PEG Ratio6-1.35
Price / Sales (TTM1)8.07
Price / Book73.38
EV4 / Revenue—
EV4 / EBITDA—
Profit Margin3.77%
Operating Margin-58.18%
Return on Equity (ROE8)-5.06%
Return on Assets (ROA9)-4.19%
Avg Volume (3M)123,250
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $420.4M | $296.7M | $170.6M | — | — |
| P/E | -9.05 | -7.24 | -4.66 | — | — |
| Price/Sales | 7.42 | 5.98 | 4.23 | — | — |
| Price/Book | 3.38 | 2.23 | 1.15 | — | — |
| EV/Revenue | 7.25 | 6.05 | 3.23 | — | — |
| ROE | -37.37% | -30.80% | -24.79% | — | — |
| ROA | -30.56% | -25.55% | -20.61% | — | — |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short630,244
Change from Prior Settlement+50.14%
% of Float—
Days to Cover (Short Ratio)3.86
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 56.0% on the provider's reported measure. Finnhub fundamentals ↗
- Trailing 52-week price return is +49.3%. Finnhub market metrics ↗
Potential concerns
- Net profit margin is 3.8%. Finnhub fundamentals ↗
- Latest SEC filing is Form 8-K, filed 2026-10-08; review it for current changes and risks. SEC EDGAR ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SI
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $17.2M | $16.7M | $11.8M | $11.0M | $10.1M | $7.5M | $8.3M | — |
| Gross profit | $13.4M | $13.0M | $9.0M | $8.4M | $7.8M | $5.7M | $6.4M | — |
| Operating income | -$10.0M | -$9.0M | -$7.6M | -$5.9M | -$4.3M | -$3.9M | -$4.0M | — |
| Net income | -$10.2M | -$8.4M | -$8.7M | -$19.2M | -$4.7M | -$4.1M | -$4.2M | -$3.6M |
| EPS (diluted) | $-0.49 | $-0.41 | $-0.64 | $-165.53 | $-52.13 | $-68.31 | $-72.74 | — |
| EPS (basic) | $-0.49 | $-0.41 | $-0.64 | $-165.53 | $-52.13 | $-68.31 | $-72.74 | — |
| Operating margin | -$58 | -$54 | -$65 | -$53 | -$42 | -$52 | -$48 | — |
| Net margin | -$59 | -$50 | -$74 | -$174 | -$46 | -$54 | -$51 | — |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $152.0M | $160.4M | $169.9M | $177.8M | $77.8M | — | $43.1M | — |
| Total liabilities | $27.7M | $27.3M | $29.2M | $29.9M | $29.3M | — | $23.3M | — |
| Stockholders' equity | $124.3M | $133.0M | $140.8M | $147.8M | -$78.2M | -$59.3M | -$54.7M | -$50.9M |
| Total current assets | $137.4M | $145.8M | $157.2M | $166.6M | $68.9M | — | $35.1M | — |
| Total current liabilities | $12.8M | $12.3M | $14.2M | $15.0M | $12.5M | — | $7.6M | — |
| Cash & equivalents | $24.5M | $11.5M | $26.9M | $54.9M | $27.1M | — | $6.1M | — |
| Accounts receivable | $10.9M | $10.5M | $8.3M | $7.1M | $6.9M | — | $5.1M | — |
| Inventory | $22.9M | $21.8M | $21.6M | $19.4M | $17.1M | — | $14.0M | — |
| Other current assets | $2.3M | $3.2M | $1.5M | $1.2M | $4.6M | — | $573.0K | — |
| Property, plant & equipment | $14.5M | $14.5M | $12.5M | $10.8M | $8.5M | — | $7.5M | — |
| Intangible assets | $0 | $25.0K | $100.0K | $175.0K | $250.0K | — | $400.0K | — |
| Other non-current assets | $33.0K | — | $0 | — | — | — | — | — |
| Accounts payable | $5.9M | $5.9M | $8.9M | $8.9M | $6.0M | — | $4.9M | — |
| Accrued liabilities | $6.9M | $6.4M | $5.3M | $6.1M | $6.4M | — | $2.7M | — |
| Long-term debt | $14.8M | $15.0M | $14.9M | $14.8M | $14.8M | — | $14.7M | — |
| Other non-current liabilities | $34.0K | $43.0K | $51.0K | $63.0K | $84.0K | — | $25.0K | — |
| Common stock & paid-in capital | $21.0K | $21.0K | $21.0K | $21.0K | $1.0K | — | $1.0K | — |
| Retained earnings | -$115.9M | -$105.8M | -$97.4M | -$89.6M | -$80.9M | — | -$57.0M | — |
| Accumulated other comprehensive income (loss) | -$104.0K | -$64.0K | $117.0K | $39.0K | $82.0K | — | $197.0K | — |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$7.4M | -$12.4M | -$8.8M | -$8.6M | -$4.8M | -$6.5M | -$3.3M | -$4.9M |
| Investing cash flow | $20.4M | -$3.1M | -$17.3M | -$72.4M | $7.2M | -$13.1M | $3.6M | $4.9M |
| Financing cash flow | -$84.0K | $101.0K | -$2.0M | $108.9M | $18.3M | $19.8M | $0 | $66.0K |
| Free cash flow | -$9.5M | -$15.1M | -$11.1M | -$11.4M | -$6.3M | -$7.3M | -$4.3M | -$5.8M |
| Capital expenditures | $2.2M | $2.7M | $2.3M | $2.8M | $1.5M | $843.0K | $1.0M | $887.0K |
| Share-based compensation | $1.1M | $726.0K | $381.0K | $298.0K | $190.0K | $127.0K | $179.0K | $237.0K |
| Change in accounts receivable | $468.0K | $2.4M | $1.2M | $240.0K | $361.0K | $1.5M | $663.0K | $60.0K |
| Change in inventory | $1.1M | $238.0K | $2.2M | $2.3M | $4.0M | -$851.0K | $1.6M | $1.4M |
| Change in accounts payable | $997.0K | -$3.2M | $1.6M | $807.0K | $3.1M | -$2.1M | $2.2M | $164.0K |
| Purchases of investments | $0 | $18.2M | $23.9M | $75.1M | $417.0K | $20.1M | $909.0K | $325.0K |
| Sales/maturities of investments | $22.6M | $17.8M | $8.9M | $5.5M | $9.1M | $7.8M | $5.6M | $6.1M |
| Debt repaid | $15.0M | — | — | — | $0 | — | — | — |
Income statement
| Line item | Dec '25 | Dec '24 |
|---|---|---|
| Revenue | $47.3M | $31.6M |
| Gross profit | $36.2M | $24.3M |
| Operating income | -$26.3M | -$14.7M |
| Net income | -$40.4M | -$15.6M |
| EPS (diluted) | $-4.65 | $-242.04 |
| EPS (basic) | $-4.65 | $-242.04 |
| Operating margin | -$56 | -$46 |
| Net margin | -$85 | -$49 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 |
|---|---|---|---|
| Total assets | $169.9M | $43.1M | — |
| Total liabilities | $29.2M | $23.3M | — |
| Stockholders' equity | $140.8M | -$54.7M | -$39.7M |
| Total current assets | $157.2M | $35.1M | — |
| Total current liabilities | $14.2M | $7.6M | — |
| Cash & equivalents | $26.9M | $6.1M | — |
| Accounts receivable | $8.3M | $5.1M | — |
| Inventory | $21.6M | $14.0M | — |
| Other current assets | $1.5M | $573.0K | — |
| Property, plant & equipment | $12.5M | $7.5M | — |
| Intangible assets | $100.0K | $400.0K | — |
| Accounts payable | $8.9M | $4.9M | — |
| Accrued liabilities | $5.3M | $2.7M | — |
| Long-term debt | $14.9M | $14.7M | — |
| Other non-current liabilities | $51.0K | $25.0K | — |
| Common stock & paid-in capital | $21.0K | $1.0K | — |
| Retained earnings | -$97.4M | -$57.0M | — |
| Accumulated other comprehensive income (loss) | $117.0K | $197.0K | — |
Cash flow
| Line item | Dec '25 | Dec '24 |
|---|---|---|
| Operating cash flow | -$28.6M | -$14.1M |
| Investing cash flow | -$95.6M | $14.0M |
| Financing cash flow | $145.0M | $66.0K |
| Free cash flow | -$36.0M | -$18.2M |
| Capital expenditures | $7.4M | $4.0M |
| Share-based compensation | $996.0K | $754.0K |
| Change in accounts receivable | $3.3M | $575.0K |
| Change in inventory | $7.6M | $4.0M |
| Change in accounts payable | $3.4M | $3.1M |
| Purchases of investments | $119.5M | $5.3M |
| Sales/maturities of investments | $31.3M | $23.3M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SI as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-02-06 to 2026-10-05
Recent transactions
- Insiders have net sold 247,243 shares over the last 182 days, across 0 purchases and 17 sales.
- Most recent: Tansey Casey M (Director) — Grant / award of 733 shares on 2026-10-05.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)247,243 sh(17 txns)
Net Shares-247,243
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Tansey Casey M | Director | Grant / award | 2026-10-05 | 733 |
| Sidow Kevin K. | Director | Grant / award | 2026-10-05 | 892 |
| Hykes Andrew | Director | Grant / award | 2026-10-05 | 669 |
| BUCKMAN PAUL | Director | Grant / award | 2026-10-05 | 1,275 |
| Ball Robert Joseph | CEO & Executive Chairman | Option exercise | 2026-09-14 | 89,233 |
| Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 2026-08-26 | 1,196 |
| Ahearn Matthew Fraser | Chief Operating Officer | Open market sale | 2026-08-18 | 12,586 |
| Buchholz Richard | Director | Grant / award | 2026-06-26 | 5,046 |
| Points Jeffrey S. | Chief Financial Officer | Option exercise | 2026-03-13 | 13,264 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-05 | Tansey Casey M | Director | Grant / award | 733 | $19.60 |
| 2026-10-05 | Sidow Kevin K. | Director | Grant / award | 892 | $19.60 |
| 2026-10-05 | Hykes Andrew | Director | Grant / award | 669 | $19.60 |
| 2026-10-05 | BUCKMAN PAUL | Director | Grant / award | 1,275 | $19.60 |
| 2026-09-14 | Ball Robert Joseph | CEO & Executive Chairman | Option exercise | 89,233 | $2.10 |
| 2026-09-14 | Ball Robert Joseph | CEO & Executive Chairman | Open market sale | 10,175 | $18.45 |
| 2026-08-26 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 1,196 | $22.60 |
| 2026-08-24 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 681 | $22.62 |
| 2026-08-21 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 20,516 | $22.61 |
| 2026-08-20 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 3,900 | $22.60 |
| 2026-08-18 | Ahearn Matthew Fraser | Chief Operating Officer | Open market sale | 12,586 | $20.94 |
| 2026-08-18 | Ahearn Matthew Fraser | Chief Operating Officer | Open market sale | 1,600 | $21.38 |
| 2026-08-17 | Ahearn Matthew Fraser | Chief Operating Officer | Open market sale | 8,314 | $20.10 |
| 2026-08-14 | Ahearn Matthew Fraser | Chief Operating Officer | Gift | 2,500 | $0.00 |
| 2026-08-06 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 2,095 | $22.60 |
| 2026-08-05 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 7,338 | $22.64 |
| 2026-08-04 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 99,812 | $22.77 |
| 2026-08-03 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 10,751 | $22.71 |
| 2026-07-31 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 20,034 | $22.73 |
| 2026-07-30 | Gilde Healthcare Holding B.V. | Reporting person | Open market sale | 28,245 | $23.36 |
| 2026-06-26 | Tansey Casey M | Director | Grant / award | 5,046 | $0.00 |
| 2026-06-26 | Sidow Kevin K. | Director | Grant / award | 5,046 | $0.00 |
| 2026-06-26 | Hykes Andrew | Director | Grant / award | 5,046 | $0.00 |
| 2026-06-26 | BUCKMAN PAUL | Director | Grant / award | 5,046 | $0.00 |
| 2026-06-26 | Buchholz Richard | Director | Grant / award | 5,046 | $0.00 |
| 2026-06-15 | Ahearn Matthew Fraser | Chief Operating Officer | Open market sale | 1,644 | $18.20 |
| 2026-06-15 | Ahearn Matthew Fraser | Chief Operating Officer | Open market sale | 2,500 | $19.26 |
| 2026-06-12 | Ahearn Matthew Fraser | Chief Operating Officer | Open market sale | 15,856 | $18.68 |
| 2026-04-30 | Ball Robert Joseph | CEO & Executive Chairman | Option exercise | 10,000 | $2.48 |
| 2026-04-20 | Ahearn Matthew Fraser | Chief Operating Officer | Option exercise | 7,421 | $2.48 |
| 2026-04-20 | Ahearn Matthew Fraser | Chief Operating Officer | Option exercise | 14,243 | $2.86 |
| 2026-03-13 | Points Jeffrey S. | Chief Financial Officer | Option exercise | 13,264 | $2.48 |
| 2026-03-13 | Points Jeffrey S. | Chief Financial Officer | Open market purchase | 2,000 | $15.00 |
| 2026-03-13 | BUCKMAN PAUL | Director | Option exercise | 19,401 | $2.48 |
| 2026-03-13 | BUCKMAN PAUL | Director | Option exercise | 26,205 | $2.10 |
| 2026-03-13 | BUCKMAN PAUL | Director | Tax withholding | 3,292 | $14.62 |
| 2026-03-13 | BUCKMAN PAUL | Director | Tax withholding | 3,714 | $14.82 |
| 2026-03-13 | Buchholz Richard | Director | Open market purchase | 1,000 | $14.84 |
| 2026-03-13 | Ball Robert Joseph | CEO & Executive Chairman | Open market purchase | 2,200 | $15.18 |
| 2026-02-06 | Ball Robert Joseph | CEO & Executive Chairman | Option exercise | 10,000 | $2.48 |
| 2026-02-06 | Ball Robert Joseph | CEO & Executive Chairman | Option exercise | 2,062 | $2.10 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:55 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-08 | 8-K | 2026-10-08 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-10-06 | 4 | 2026-10-05 | View on SEC.gov → |
| 2026-09-14 | 4 | 2026-09-14 | View on SEC.gov → |
| 2026-08-28 | 4 | 2026-08-26 | View on SEC.gov → |
| 2026-08-24 | 4 | 2026-08-20 | View on SEC.gov → |
| 2026-08-18 | 4 | 2026-08-14 | View on SEC.gov → |
| 2026-08-10 | 8-K | 2026-08-10 | View on SEC.gov → |
| 2026-08-07 | 4 | 2026-08-05 | View on SEC.gov → |
| 2026-08-06 | 10-Q | 2026-06-30 | View on SEC.gov → |
Recent news
Headlines about SI (Shoulder Innovations, Inc.). Links open the publisher — we don’t host full articles.
-
NIO Inc. (NIO.SI) Stock Price, News, Quote & History
Yahoo! Finance Canada · 2026-10-21 -
Keppel REIT (K71U.SI) interactive stock chart – Yahoo Finance
Yahoo Finance Singapore · 2026-10-21 -
Singapore Shares Surge Despite Rising Oil Prices, Concerns Over AI Investment
Yahoo Finance Singapore · 2026-10-21 -
First Resources Limited (EB5.SI) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-21 -
SK hynix Inc. (UNXD.SI) latest stock news and headlines
Yahoo Finance UK · 2026-10-21 -
UOL Group Limited (U14.SI) stock price, news, quote and history
Yahoo Finance Singapore · 2026-10-21 -
Wedbush’s Ives reiterates Outperform on SpaceX stock citing SI growth
Investing.com · 2026-10-20 -
Dabo Swinney Shares Positive Injury Update on QB Christopher Vizzina Ahead of Virginia Tech
Sports Illustrated · 2026-10-20
No headlines in this category right now — try “All”.